Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Sales | 0 | 0 | 0 | 0 | 1 |
| Cost of Goods | 0 | 0 | 0 | 1 | 0 |
| Gross Profit | 0 | 0 | 0 | -1 | 1 |
| Operating Expenses | 40 | 28 | 52 | 97 | 48 |
| Operating Income | -40 | -28 | -52 | -98 | -48 |
| Interest Expense | 42 | 42 | 39 | 36 | 32 |
| Other Income | -1 | 18 | -16 | 288 | -2 |
| Pre-tax Income | -84 | -52 | -107 | 154 | -82 |
| Net Income Continuous | -84 | -52 | -107 | 154 | -82 |
| Net Income | $-84 | $-52 | $-107 | $154 | $-82 |
| EBITDA(a) | $-41 | $-9 | $-68 | $191 | $-49 |